Regavirumab
Entry
D09852 Drug
Name
Regavirumab (JAN/INN)
Efficacy
Antiviral
Comment
Monoclonal antibody
Target
HCMV envelope glycoprotein B [KO:K22773]
Pathway
ko05163
Human cytomegalovirus infection
Brite
Antimicrobials [BR:br08307]
Antivirals
Entry, fusion or uncoating inhibitor
Herpesvirus glycoprotein
D09852 Regavirumab (JAN/INN)
BRITE hierarchy
Other DBs
CAS:
153101-26-9
PubChem:
124490591